ND-13, a DJ-1-derived peptide, has shown promise in treating Parkinson’s disease by activating the Nrf2 antioxidant pathway, lowering reactive oxygen species, and enhancing motor function [53]. The gene discussed is PARK7; the disease is Parkinson disease.